Last reviewed · How we verify
Reference001 type II
At a glance
| Generic name | Reference001 type II |
|---|---|
| Sponsor | Sun Pharma Advanced Research Company Limited |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Bioavailability Study of SPARC001(Study 1) in Healthy Adult Volunteers (PHASE1)
- Bioavailability Study of SPARC001 (Study 2) in Healthy Adult Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Reference001 type II CI brief — competitive landscape report
- Reference001 type II updates RSS · CI watch RSS
- Sun Pharma Advanced Research Company Limited portfolio CI